Literature DB >> 406671

An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum.

W A Siddiqui.   

Abstract

This is the first report of successful immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum. Of the five owl monkeys (Aotus trivirgatus) used in this pilot study, two served as controls and the other three were immunized with P. falciparum antigen consisting primarily of mature segmenters containing fully developed merozoites. Two injections of antigen emulsified with Freund's complete adjuvant were administered intramuscularly 3 weeks apart. Three weeks after the second vaccination, all monkeys were challenged with the homologous strain of P. falciparum. The control monkeys died with high levels of parasitemia within 2 weeks of challenge. The three immunized monkeys survived and showed strong protection against P. falciparum. These results are encouraging for the possible future development of an effective vaccine against human malaria.

Entities:  

Mesh:

Year:  1977        PMID: 406671     DOI: 10.1126/science.406671

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  35 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 3.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 4.  Malaria vaccines since 2000: progress, priorities, products.

Authors:  Patrick E Duffy; J Patrick Gorres
Journal:  NPJ Vaccines       Date:  2020-06-09       Impact factor: 7.344

5.  Harvest of Plasmodium falciparum merozoites from continuous culture.

Authors:  J E Mrema; G H Campbell; A L Jaramillo; R Miranda; K H Rieckmann
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

6.  Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys.

Authors:  W A Siddiqui; L Q Tam; S C Kan; K J Kramer; S E Case; K L Palmer; K M Yamaga; G S Hui
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

7.  Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum.

Authors:  M J McGarvey; E Sheybani; M P Loche; L Perrin; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.

Authors:  A Cheung; J Leban; A R Shaw; B Merkli; J Stocker; C Chizzolini; C Sander; L H Perrin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Role of the surface coat in in vitro attachment and phagocytosis of Plasmodium berghei by peritoneal macrophages.

Authors:  C Brooks; J P Kreier
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

10.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.